Answers are grounded in this paper and cite their sources.
Our results are relevant to HIV vaccine development efforts because they suggest that increasing the number of booster immunizations or delivering additional viral antigens may not necessarily improve vaccine efficacy against immunodeficiency virus infection.
No takes yet. Share an insight, caveat, or question.
Martins et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: